| 000 | 01542 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513070741.0 | ||
| 264 | 0 | _c19940203 | |
| 008 | 199402s 0 0 eng d | ||
| 022 | _a1064-1963 | ||
| 024 | 7 |
_a10.3109/10641969309037081 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoyé, L A | |
| 245 | 0 | 0 |
_aConclusions and implications of the systolic hypertension in the elderly program. _h[electronic resource] |
| 260 |
_bClinical and experimental hypertension (New York, N.Y. : 1993) _cNov 1993 |
||
| 300 |
_a911-24 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAtenolol _xtherapeutic use |
| 650 | 0 | 4 | _aBlood Pressure |
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xepidemiology |
| 650 | 0 | 4 |
_aDiuretics _xtherapeutic use |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aSystole |
| 700 | 1 | _aDavis, B R | |
| 700 | 1 | _aHawkins, C M | |
| 700 | 1 | _aProbstfield, J L | |
| 773 | 0 |
_tClinical and experimental hypertension (New York, N.Y. : 1993) _gvol. 15 _gno. 6 _gp. 911-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/10641969309037081 _zAvailable from publisher's website |
| 999 |
_c8268179 _d8268179 |
||